St3gal3 - ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Gene
Also Known as Siat6
Species: Rattus norvegicus
Summary
Predicted to enable beta-galactoside (CMP) alpha-2,3-sialyltransferase activity. Predicted to be involved in ganglioside biosynthetic process via lactosylceramide and protein glycosylation. Predicted to be located in Golgi cisterna membrane and extracellular region. Predicted to be integral component of membrane. Human ortholog(s) of this gene implicated in autosomal recessive non-syndromic intellectual disability and developmental and epileptic encephalopathy 15. Orthologous to human ST3GAL3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3). [provided by Alliance of Genome Resources, Apr 2022]
St3gal3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_031697.1 | NP_113885.1 | CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-172888 | SPP-037 | Inhibitor | / | Unkown |
| HY-RS13848 | ST3GAL3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18441 | St3gal3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24923 | St3gal3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service